These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 926602)

  • 21. [Practical use of cardiac glycosides].
    Ignat'ev MV
    Voen Med Zh; 1976 Sep; (9):78-80. PubMed ID: 1034366
    [No Abstract]   [Full Text] [Related]  

  • 22. [Studie on the problem of long-term therapy using cardiac glycosides].
    Basche-Langer M; Schmidt-Voigt J; Klepzig H
    Dtsch Med Wochenschr; 1968 Nov; 93(48):2338-41. PubMed ID: 5696573
    [No Abstract]   [Full Text] [Related]  

  • 23. [Use of sirenid in the treatment of circulatory insufficiency in patients with cardiac fibrillation].
    Adamova NS
    Vrach Delo; 1965 Sep; 9():130-2. PubMed ID: 5871465
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of cardiac insufficiency with beta-methyldigoxin and the clinical significance of the blood concentration of digitalis glycosides].
    Tomov L; Tomov I; Orbetsov M; Todorova M; Visheva N
    Vutr Boles; 1977; 16(1):36-44. PubMed ID: 898908
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of glucagon in cardiac insufficiency].
    Golikov AP; Berestov AA
    Kardiologiia; 1975 Oct; 15(10):62-5. PubMed ID: 1234916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of vitamin B 15 on myocardial contractility and cardiotonic effect of strophanthin in ischaemic heart disease.
    Apanasenko AA
    Cor Vasa; 1973; 15(1):20-8. PubMed ID: 4703670
    [No Abstract]   [Full Text] [Related]  

  • 27. [Spiroergometric evaluation of the effectiveness of treatment of cardiac insufficiency with cardiac glycosides].
    Krol VA; Khamrakulova DS
    Kardiologiia; 1977 Sep; 17(9):51-3. PubMed ID: 926601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of cardiac glycosides of strophanthin series during experimental disorders of the coronary circulation].
    Azizova SS
    Farmakol Toksikol; 1968; 31(4):421-4. PubMed ID: 5698130
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cardiac glycoside treatment of children with rheumatic fever and circulatory insufficiency].
    Borisova TP; Serbin VI
    Vopr Okhr Materin Det; 1972 Apr; 17(4):7-11. PubMed ID: 5081438
    [No Abstract]   [Full Text] [Related]  

  • 30. [Intramuscular strophanthin therapy].
    Iványi J
    Z Arztl Fortbild (Jena); 1965 Apr; 59(8):452-5. PubMed ID: 5887307
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of treatment with cardiac glycosides and biologically active substances on the state of the lesser circulation according to the electrokymographic data].
    Masliuk VI; Polosova TA; Neporent MI; Abbakumov SA; Shatikhin AI
    Kardiologiia; 1977 Sep; 17(9):42-6. PubMed ID: 926599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Studies on the relationships between the glycoside dosage effect and pulse frequency behavior].
    Döring D; Wenzel V
    Z Gesamte Inn Med; 1966 Jun; 21(12):Suppl:137-8. PubMed ID: 5987624
    [No Abstract]   [Full Text] [Related]  

  • 33. [Present-day cardiac glycoside therapy].
    Larbig D
    Pol Arch Med Wewn; 1976 Dec; 56(6):551-65. PubMed ID: 794849
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of chronic right-heart lesions. Proscillaridin for cor pulmonale and the senile heart.
    Neumann H
    Geriatrics; 1966 Jun; 21(6):180-5. PubMed ID: 5949184
    [No Abstract]   [Full Text] [Related]  

  • 35. [Efficacy of cardiac glycosides in circulatory insufficiency].
    Vizir AD
    Vrach Delo; 1969 Nov; 11():39-42. PubMed ID: 5384419
    [No Abstract]   [Full Text] [Related]  

  • 36. [Modern cardiac glycoside therapy].
    Bonelli J
    Wien Med Wochenschr; 1978; 128(22):689-96. PubMed ID: 735108
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of the sugar component in cardiac glycosides on their action in patients with auricular fibrillation and congestive failure.
    Gold H; Kwit NT; Shane SJ; Dayrit C
    J Clin Pharmacol J New Drugs; 1969; 9(3):148-54. PubMed ID: 5255179
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of circulatory disorders with corglycon in rheumatic children].
    Ostropolets' SS
    Pediatr Akus Ginekol; 1965; 4():22-4. PubMed ID: 5888228
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prophylactic use of cardiac glycosides in patients with ischemic heart disease].
    Komarov FI; Rabkin IKh; Ol'binskaia LI; Kitaeva IT; Abugov AM
    Ter Arkh; 1974; 46(9):29-35. PubMed ID: 4439302
    [No Abstract]   [Full Text] [Related]  

  • 40. [Electroca rdiographic control in clinical use of mean therapeutic doses of cardiac glycosides (strophanthin, corglycon)].
    Fan-Tkhi-Ngok-Shiong
    Ter Arkh; 1974; 46(6):83-9. PubMed ID: 4473844
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.